Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nostoc punctiforme (Npu) DnaE split intein is a highly efficient protein element derived from the cyanobacterium Nostoc punctiforme that facilitates protein trans-splicing (PTS). In this process, the N-terminal (IntN) and C-terminal (IntC) fragments of the intein spontaneously associate with high affinity to form a catalytically active domain, which then excises itself while ligating the flanking protein sequences, known as exteins, with a peptide bond (Iwai et al., 2006, FEBS Lett). This specific intein is noted for its exceptionally fast splicing kinetics and high tolerance for various extein sequences, making it a premier tool in chemical biology and protein engineering (Shah et al., 2011, J Am Chem Soc). In the realm of therapeutics, Npu DnaE is primarily employed in gene therapy to overcome the limited cargo capacity of viral delivery vehicles like Adeno-associated virus (AAV). By splitting large therapeutic proteins, such as the CRISPR/Cas9 system or the dystrophin protein, into two fragments delivered by separate vectors, the functional protein can be reconstituted in vivo (Li et al., 2008, Hum Gene Ther). While it is not a target for traditional small-molecule inhibition, its use as a therapeutic platform necessitates careful consideration of the immunogenic potential of bacterial proteins in human patients (Tornabene et al., 2019, Sci Transl Med). Furthermore, the efficiency of the splicing reaction in different tissue types remains a critical factor for the success of intein-mediated dual-vector therapies (Zhu et al., 2010, J Biol Chem).
Protein trans-splicing (PTS) mediated by the spontaneous, non-covalent association of split intein fragments to catalyze peptide bond formation between flanking exteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nostoc punctiforme DnaE split intein (Npu DnaE).